Druzgala Pascal 4
4 · ARYx Therapeutics, Inc. · Filed Feb 20, 2009
Insider Transaction Report
Form 4
Druzgala Pascal
Sr. V.P. & Chief Scien.Off.
Transactions
- Award
Stock Option (Right to Buy)
2009-02-18+60,000→ 60,000 totalExercise: $2.70Exp: 2019-02-17→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on February 18, 2010 and one forty-eighth (1/48th) of the shares shall vest monthly thereafter.